Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Picks Intec W&G to Sell Its Pharmacogenomics Tools in Japan

NEW YORK, Feb. 6 - Genaissance Pharmaceuticals on Wednesday said it has tapped Japan's Intec Web & Genome Informatics Corporation to market all of its pharmacogenomics applications and products to pharmaceutical, diagnostic, and biotechnology companies in that country.


Financial terms of the agreement were not disclosed.

Genaissance's efforts to strike out in Japan will give it access to the second-largest pharma market in the world and the approximately 600 pharma and biotech companies there.

"With Intec W&G as our Japanese sales representative, Genaissance is expanding its potential market reach to a country that is second only to the US in pharmaceutical sales," Kevin Rakin, president and CFO of Genaissance, said in a statement.

Munehiro Sueoka, president of Intec W&G, added: "Here in Japan, we intend to replicate the success Genaissance has achieved with US and European biopharmaceutical companies. We view the collaboration as an opportunity to expand our leadership in providing the best new technologies to our clients in Japan."

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.